Strata Critical Medical, Inc.
SRTA Healthcare Medical Care Facilities
In the quarter to June 2026, revenue grew 60.7%, EPS fell 140.0% and free cash flow grew 150.3%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
Follow SRTA
Strata Critical Medical, Inc. (SRTA) Piotroski F-score
Strata Critical Medical, Inc.'s Piotroski F-score for fiscal 2025 is 5 out of 9: 5 of nine tests of profitability, leverage and efficiency passed, unchanged from fiscal 2024.
Piotroski F-score, annual
Embed this chart
Annual newest first
| Period | Piotroski F-score | Change (points) |
|---|---|---|
| FY2025 | 5 | 0.00 |
| FY2024 | 5 | 1.00 |
| FY2023 | 4 | — |
How fiscal 2025’s score is made up
| Test | This year | Year before | Result | Points |
|---|---|---|---|---|
| Positive return on assets | 14.21% | (9.90%) | Pass | 1 |
| Positive operating cash flow | (48.91m) | (2.52m) | Fail | 0 |
| Rising return on assets | 14.21% | (9.90%) | Pass | 1 |
| Cash flow above net income | (90.26m) | 24.79m | Fail | 0 |
| Falling long-term leverage | 0.00 | 0.00 | Pass | 1 |
| Rising current ratio | 6.38 | 7.07 | Fail | 0 |
| No new shares issued | 82,092,000 | 77,499,000 | Fail | 0 |
| Rising gross margin | 20.86% | 20.15% | Pass | 1 |
| Rising asset turnover | 0.68 | 0.53 | Pass | 1 |
| Piotroski F-score | Mixed | 5 | ||
How the Piotroski F-score works
One point for each of nine tests, this fiscal year against the one before: positive return on assets, positive operating cash flow, rising return on assets, cash flow above net income, falling long-term leverage, a rising current ratio, no new shares issued, a rising gross margin and rising asset turnover. The ratios are the ones on this site, so each can be checked.
Joseph Piotroski (2000) called 8–9 high and 0–1 low; reading it in three bands is the common convention:
| 7–9 | Strong — most fundamentals improved |
|---|---|
| 4–6 | Mixed |
| 0–3 | Weak — most fundamentals deteriorated |
Where this differs from the paper: return on assets is on average rather than beginning-of-year assets, and weighted basic shares stand in for shares issued. The score is shown only when all nine tests can be worked out, which takes three fiscal years; banks and insurers, which report no current assets or gross profit, have none.
Piotroski F-score against peers
| Company | Piotroski F-score |
|---|---|
| CYH Community Health Systems, Inc. compare | 8 |
| NUTX Nutex Health Inc. compare | 7 |
| USPH U.S. Physical Therapy, Inc. compare | 7 |
| INNV InnovAge Holding Corp. compare | 6 |
| AUNA Auna S.A. compare | 5 |
| SRTA Strata Critical Medical, Inc. | 5 |
| STLN Starling Oncology, Inc. compare | 4 |
| AIRS AirSculpt Technologies, Inc. compare | 3 |
| MCTA Charming Medical Limited compare | 2 |
What Piotroski F-score is
The Piotroski F-Score tells an investor how many signs of improving profitability, funding and efficiency a company shows against a year earlier.
One point for each of nine tests against a year earlier: positive return on assets, positive operating cash flow, rising return on assets, cash flow above net income, falling long-term leverage, rising current ratio, no new shares issued, rising gross margin, and rising asset turnover